Media not available due to technical recording problems. EVRS is very sorry for the inconvenience.

 

Introduction:

Macular edema is one of the main causes of severe vision loss in patients with diabetic retinopathy. In the presence of hard exudates, the prognosis is frequently unfavorable.

Setting:

Ophthalmology Department, Hospital de Braga, Portugal.

Purpose:

To evaluate the safety and efïcacy of suprachoroidal drug delivery with a microcatheter for the treatment of subfoveal hard exudates.

Methods:

Eight eyes of eight patients with diabetic macular edema associated with subfoveal hard exudates were submitted to a single treatment with bevacizumab and triamcinolone administered to the suprachoroidal space, using a microcatheter.

Results:

Clinical and optical coherence tomographic evaluations of these patients were performed over 6 months follow-up. There were no surgical or postoperative complications. The visual acuity remais stable, although the decrease of the hard exudates.